Contact your trial team or GP promptly if you experience: Persistent or severe nausea, vomiting, or diarrhoea that prevents adequate fluid or food intake Signs of dehydration, such as dizziness, dark urine, or reduced urination Severe or persistent abdominal pain, which may rarely indicate pancreatitis a known risk with GLP-1 receptor agonist therapies or gallbladder problems [18] [21] Rapid or irregular heartbeat (palpitations) Significant injection site reactions, including signs of infection (redness, warmth, swelling, or discharge) Symptoms of low blood sugar (hypoglycaemia) if you are also taking insulin or a sulfonylurea, such as shakiness, sweating, or confusion If you are unsure whether your symptoms require urgent attention, contact NHS 111 (by phone or online at 111.nhs.uk) for advice
The patient expressed satisfaction with their progress, stating, Im not that hungry all the time due to medication and portion control
meaning no side effects such as what we see with pharmaceuticals
Its an experimental drug, and theres no evidence that the BPC-157 peptide is effective or safe in humans
Our Content Integrity Team ensures that the business practices and medical claims of every service we feature align with our standards of integrity and approach to well-being